Faculty & Staff Details

	Name:	Eric MacLaughlin,PharmD,FCCP,BCPS
	Position:	Professor and Head of Adult Medicine Division, Amarillo
	Email:	eric.maclaughlin@ttuhsc.edu
	Bio	Eric MacLaughlin, Pharm.D., FCCP, BCPS is Professor and Division Head of Adult Medicine, Department of Pharmacy Practice at Texas Tech University Health Sciences Center School of Pharmacy. He is also a Professor in the Department of Family Medicine and Internal Medicine at TTUHSC School of Medicine. He received his B.S. in Pharmacy from Albany College of Pharmacy, Pharm.D. from the Medical University of South Carolina, and completed a Primary Care Specialty Residency at the University of Colorado. His practice specialty is family medicine (inpatient and outpatient). Dr. MacLaughlin’s research interests include management of hypertension, prevention and of treatment of osteoporosis, and education of healthcare professionals.

Education:

• Post Doctoral Primary Care Specialty Residency (ASHP Accredited), University of Colorado Health Sciences Center, School of Pharmacy, Denver, Colorado, 07/1997 – 07/1999.
• Doctor of Pharmacy, Medical University of South Carolina, School of Pharmacy, Charleston, South Carolina, 08/1996 – 05/1998.
• Bachelor of Science in Pharmacy, Albany College of Pharmacy, Albany, New York, 08/1991 – 05/1996.

Licensures:

• Texas, #38616, 07/1999 - present
• Texas Preceptor, 08/1999 - present
• South Carolina, #009113, 06/1996 - present

Certifications

• Board Certified Pharmacotherapy Specialist, Credential #200198, 12/2000; recertified 12/2007.
• Basic Cardiac Life Support, American Heart Association, 06/1996-present

Honors and Awards

Teaching Recognitions

• “P2 Teacher of the Year Award”, TTUHSC School of Pharmacy Class of 2014, 04/20/2012.
• “P2 Teaching Team of the Year Award” for Cardiovascular Pharmacotherapy Course, Role: Course Coordinator, TTUHSC School of Pharmacy Class of 2014, 04/20/2012
• “Teacher Appreciation” Recognition and Plaque, TTUHSC School of Medicine, Department of Family Medicine, Residency Class of 2011, 06/24/2011.
• “Most Influential Professor”, TTUHSC School of Pharmacy Class of 2011, 05/20/2011.
• “P2 Teaching Team of the Year Award” for Cardiovascular Pharmacotherapy Course, Role: Course Coordinator, TTUHSC School of Pharmacy Class of 2012, 04/29/2011.
• “Outstanding Teacher of the Year” for TTUHSC School of Pharmacy, TTUHSC Lubbock Student Senate, 04/2010.
• “P2 Teaching Team of the Year Award” for Cardiovascular Pharmacotherapy Course, Role: Course Coordinator, TTUHSC School of Pharmacy Class of 2012, 04/30/2010.
• “P2 Teaching Team of the Year Award” for Cardiovascular Pharmacotherapy Course, Role: Course Coordinator, TTUHSC School of Pharmacy Class of 2011, 05/01/2009.
• “Unsung Hero Award”, TTUHSC Student Senate, Amarillo campus, 04/30/2009.
• “P3 Teaching Team of the Year Award” for Bone and Joint Pharmacotherapy Course, Role: Team member, TTUHSC School of Pharmacy Class of 2009, 05/2008.
• Foreign Visiting Teaching Professor, Kobe Gakuin University, Kobe, Japan, 2002.
• “Teaching Team of the Year Award” for Musculoskeletal Pharmacotherapy Course, Class of 2001, Role: Team member, TTUHSC School of Pharmacy, 05/2000.

Clinical Practice Recognitions

• Chair (elected): Board of Pharmacy Specialties, Specialty Council of Pharmacotherapy, 2012-2013.
• Chair (elected): Board of Pharmacy Specialties, Specialty Council of Pharmacotherapy, 2011-2012.
• Vice-Chair (elected): Board of Pharmacy Specialties, Specialty Council of Pharmacotherapy, 2010-2011.
• Fellow: American College of Clinical Pharmacy (ACCP), 10/2008.
• Appointee: ACCP Representative for Pharmacotherapy Specialist Council, Board of Pharmaceutical Specialty Council, 2008-2010.
• Chair (elected): ACCP Ambulatory Care Practice and Research Network, Chair-elect 2006-2007, Chair 2007-2008.
• “Texans Caring for Texans Public Service Award”, State of Texas, 08/2006.
• Appointed Member: Joint Commission Technical Advisory Panel on Osteoporosis, 04/2006-present.
• 1st Place Poster, Administrative Category: “Implementation and Analysis of a Pharmacy School-Based Drug Plan for Low Income Patients”, Texas Society of Health-System Pharmacists (TSHP) Annual Seminar, Austin, TX, 04/2005.
• Treasurer (elected): ACCP Ambulatory Care Practice and Research Network, 2004-2006.
• “Lewis S. Smith Pharmacy Practitioner Award”, Texas Society of Health-System Pharmacists, 2003.
• Active Teacher in Family Medicine, American Academy of Family Physicians, 2000.

Academic and Leadership Recognitions

• Elected Faculty Affairs Committee Member, TTUHSC School of Pharmacy, 2011-2013.
• Faculty Inductee: Phi Lambda Sigma, National Pharmacy Leadership Society, 02/2009.
• Executive Committee Member, TTUHSC School of Pharmacy, 2001-2002.
• “Once Pharmacy Now Other Profession” (OPNOP) Scholarship, MUSC, 1997.
• “Earl D. Rhodes Award”, Albany College of Pharmacy, 1996.
• “Kappa Psi Scholastic Achievement Award”, Albany College of Pharmacy, 1995-1996.
• Becton Dickinson/Thrift Drug Scholarship, 1995.
• ASHP Patient Counseling Competition Winner, Albany College of Pharmacy, 1995.

Research Interests:

Dr. MacLaughlin’s research interests include management of cardiovascular diseases (e.g., hypertension, hyperlipidemia, congestive heart failure), prevention and of treatment of osteoporosis, and health professions education.

Publications:

Peer Reviewed Book Chapters

1. Saseen JJ, MacLaughlin EJ. Chapter 19, Hypertension. In: Dipro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM, eds. Pharmacotherapy: A Pathophysiologic Approach. 8th ed. New York, NY: McGraw-Hill; 2011:101-135.

2. Saseen JJ, MacLaughlin EJ. Chapter 15, Hypertension. In: Dipro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM, eds. Pharmacotherapy: A Pathophysiologic Approach. 7th ed. New York, NY: McGraw-Hill; 2008:139-171.

Peer Reviewed Manuscripts ( *corresponding author, original research)

1. Rojas-Fernandez CH, MacLaughlin EJ, Dore NL, Ebsary S. Assessing the potential adverse consequences of supplemental calcium on cardiovascular outcomes: should we change our approach to bone health? Ann Pharmacother. 2012;46(5):696-702.

2. Burgess SE, MacLaughlin EJ*, Smith PA, Salcido A, Benton TJ. Blood pressure rising: differences between current clinical and recommended measurement techniques. J Am Soc Hypertens. 2011;5(6):484-488.

3. MacLaughlin EJ, Saseen JJ. Use of diuretics in women with hypertension. Curr Hypertens Rev. 2011;7(1):54-58.

4. Tadevosyan A, MacLaughlin EJ, Karamyan VT. Angiotensin II type 1 receptor antagonists in the treatment of hypertension in elderly patients – focus on patient outcomes. Patient Relat Outcome Meas. 2011;2:27-39.

5. MacLaughlin EJ*, Fike DS, Alvarez CA, Seifer CF, Blaszczyk AT. Reliability of a seminar grading rubric in a grand rounds course. J Multidiscip Healthc. 2010;3:169-179.

6. MacLaughlin EJ*, Fike DS, Alvarez CA, Seifer CF, Blaszczyk AT. Reliability of a seminar grading rubric in a grand rounds course. J Multidiscip Healthc. 2010;3:1-7 (In press).

7. MacLaughlin EJ, Saseen JJ. Use of diuretics in women with hypertension. Menopause Manag. (Accepted 05/12/2010).

8. MacLaughlin EJ. Improving osteoporosis screening, risk assessment, diagnosis, and treatment initiation: role of the health-system pharmacist in closing the gap. Am J Health Syst Pharm. 2010;67:s4-s8.

9. MacLaughlin EJ. Promoting bone health: focus on postmenopausal woman and patients receiving systemic therapy for breast or prostate cancer. Introduction. Am J Health Syst Pharm. 2010;67:s2-s3.

10. MacLaughlin EJ, Haase MR, Irons BK, McCall KL, Sleeper RB, Patry RA, Raehl CL. Assessing an academic pharmacy position: guidelines for evaluating an institution and roles for new faculty. Curr Pharm Teach Learn. 2009;1:17-24.

11. Aylor AL, Koen S, MacLaughlin EJ, Zoller D. Compliance with and understanding advance directives in trainee doctors. J Miss State Med Assoc. 2009;50:3-7.

12. American College of Clinical Pharmacy, Boyce EG, Burkiewicz JS, Haase MR, MacLaughlin EJ, Segal AR, Chung EP, Lingtak-Neander C, Rospond RM, Barone, J, Durst SW, Wells BG. Position Statement: Clinical faculty development. Pharmacotherapy. 2009;29:124-126.

13. American College of Clinical Pharmacy, Boyce EG, Burkiewicz JS, Haase MR, MacLaughlin EJ, Segal AR, Chung EP, Lingtak-Neander C, Rospond RM, Barone, J, Durst SW, Wells BG. Essential components of a faculty development program. Pharmacotherapy. 2009;29:127.

14. MacLaughlin EJ, Raehl CL, Reilly C. Celiac disease and osteoporosis [letter]. Am J Health Syst Pharm. 2008;65;161-1602.

15. Gallegos PJ, MacLaughlin EJ*, Haase KK. Emerging use of brain natriuretic peptide for monitoring and titration of drug therapy in patients with heart failure. Pharmacotherapy. 2008;28:343-355.

16. MacLaughlin EJ,* Raehl CL. ASHP therapeutic position statement on the prevention and treatment of osteoporosis in adults. Am J Health Syst Pharm. 2008;65:343-57.

17. Raehl CL, MacLaughlin EJ, Leeper S, Bond CA, Patry RA. Early implementation of Medicare Part D in urban and rural nursing homes. Consult Pharm. 2007;22:744-53

18. McCall KL, MacLaughlin EJ, Fike DS, Ruiz B. Preadmission predictors of NAPLEX success and failure: an analysis of six graduating classes. Am J Pharm Educ. 2007;71(1):Article 05.

19. MacLaughlin EJ,* Sleeper RB, McNatty D, Raehl CL. Management of age-related osteoporosis and prevention of associated fractures. Ther Clin Risk Manage. 2006;2:281-295.

20. Sanghi S, MacLaughlin EJ, Jewell CW, Chaffer S, Watson LE, Dostal DE. Cyclooxygenase-2 inhibitors: a painful lesson. Curr Drug Targets Cardiovasc Haematol Disord. 2006;6:85-100.

21. MacLaughlin EJ, Raehl CL, Treadway AK, Sterling TL, Zoller DP, Bond CA. Assessing medication adherence in the elderly: which tools to use in clinical practice? Drugs Aging. 2005;22:231-255.

22. MacLaughlin EJ,* MacLaughlin AA, Snella KA, Winston TS, Fike DS, Raehl CR. Osteoporosis screening and education in community pharmacies using a team approach. Pharmacotherapy. 2005;25:379-386.

23. MacLaughlin EJ, Akaho E, Hirai M, Kambara H, Kawasaki K. An update on community pharmacy practice in the United States. Jpn J Pharm Health Care Sci. 2004;30:505-510.

24. MacLaughlin EJ,* Supernaw RB, Howard KA. Impact of distance-learning using videoconferencing technology on student performance. Am J Pharm Educ. 2004;68(3):Article 58.

25. Raehl CL, MacLaughlin EJ, Bond CA. Upgrading nontenure-track pharmacy practice faculty from second-to first-class citizens. Am J Pharm Educ. 2003;67(4):Article 115.

26. Akaho E, MacLaughlin EJ*, Takeuchi Y. Comparison of prescription reimbursement methodologies between Japan and the United States. J Am Pharm Assoc. 2003;43:519-26.

27. McCall KL, MacLaughlin EJ. Ximelagatran: a new era in oral anticoagulation. J Pharm Tech. 2003;9:222-8.

28. Saseen JJ, MacLaughlin EJ, Westfall JM. Treatment of uncomplicated hypertension: Are ACE inhibitors and calcium channel blockers as effective as diuretics and beta-blockers? J Am Board Fam Pract. 2003;16:156-64.

29. MacLaughlin EJ,* Fitzpatrick KT, Sbar E, Jewell C. Anaphylactoid reaction to enoxaparin. Pharmacotherapy. 2002;22:1511-1515.

30. Irons BK, Snella KA, McCall KL, MacLaughlin EJ, Villareal M. Update on the management of dyslipidemia: a case-based primer using current national guidelines. Am J Health Syst Pharm. 2002;59:1615-25.

31. McCall KL, MacLaughlin EJ. Warfarin-associated bleeding complication saved life. Pharmacotherapy. 2002;22:265-8.

32. Mehos BH, Saseen JJ, MacLaughlin EJ. Effect of home blood pressure monitoring on patients with uncontrolled primary hypertension. Pharmacotherapy. 2000;20:1384-1389.

33. MacLaughlin EJ, Saseen JJ, Malone DC. Costs of beta-lactam allergies: selection and costs of antibiotics for patients with a reported beta-lactam allergy. Arch Fam Med. 2000;9:722-726.

34. MacLaughlin EJ, Saseen JJ. Importance of identifying foreign drugs [letter]. Am J Health Syst Pharm. 1999;56:2349-2350.

35. Saseen JJ, MacLaughlin EJ. Appetite stimulants and anabolic steroid therapy for AIDS wasting. AIDS Read. 1999;9:398-407.

Acknowledged Site Co-Investigator

1. Carter BL, Clarke W, Ardery G, et al.; Collaboration Among Pharmacists Physicians To Improve Outcomes Now (CAPTION) Trial Investigators. A cluster-randomized effectiveness trial of a physician-pharmacist collaborative model to improve blood pressure control. Circ Cardiovasc Qual Outcomes 2010;3;418-423.

Non-Peer Reviewed ( *corresponding author)

1. Bartlett C, MacLaughlin EJ*. The pharmacist’s role in ambulatory care. Panhandle Health. 2011;

2. Thomason KR, Barnett LE, MacLaughlin EJ*. Using performance enhancing drugs to gain an edge in a competitive world of sports. Panhandle Health. 2008;18(4):19-20,29.

3. Brown J, MacLaughlin EJ*. A brief history of the discovery and development of antibiotics. Panhandle Health. 2008;18(3):38-40.

4. MacLaughlin EJ, Akaho E, Kawasaki K. [Pharmacy management and functions of pharmacist in USA: part 2]. J Hyogo Pharm Society. 2003;565:65-7.

5. MacLaughlin EJ, Akaho E, Kawasaki K. [Pharmacy management and functions of pharmacist in USA: part 1]. J Hyogo Pharm Society. 2003;564:44-8.

6. MacLaughlin EJ,* Reddy IK. Asthma: pathogenesis, triggers, diagnosis, and treatment. Drug Store News. October 2000:24-8.

7. MacLaughlin EJ,* Saseen JJ. Currentness of foreign drug list [reply]. Am J Health Syst Pharm. 2000;57:1362-3.

8. MacLaughlin EJ.* Using statins to treat hypertriglyceridemia. National Pharmacy Cardiovascular Council Fat Facts. 1999;7:1-2.

9. MacLaughlin EJ.* Treating chronic hepatitis B with lamivudine. Inf Dis News. 1999;12(2):21.

10. MacLaughlin EJ.* Use of anabolic steroids in HIV/AIDS wasting syndrome. Inf Dis News. 1998;11(11):17.

11. MacLaughlin EJ.* New dosing for an old drug: BID dosing of amoxicillin. Inf Dis News. 1998;11(10):32.

12. MacLaughlin EJ.* Current treatment strategies for onychomycosis. Inf Dis News. 1998;11(9):17.

13. MacLaughlin EJ.* A comparison of the new fluoroquinolones. McCleod Fam Tree. 1998(Spring):11.

International Peer-Reviewed Abstracts/Platform Presentations ( *corresponding author)

1. MacLaughlin EJ,* MacLaughlin AA, Snella KA, Overton T, Winston TS, Fike DS, Raehl CL. Osteoporosis Screening and Education in Community Pharmacies Using a Team Approach. Abst #PC-104. American College of Clinical Pharmacy–European Society of Clinical Pharmacists International Congress on Clinical Pharmacy, Paris France, 2004.

2. MacLaughlin EJ,* Saseen JJ, Klepser TB, Culhane NS, Goode JV, Kanous NL. ACCP Ambulatory Care Practice and Research Network (PRN): Assessment of Membership Needs and Diversity. Abst #EDU-003. American College of Clinical Pharmacy–European Society of Clinical Pharmacists International Congress on Clinical Pharmacy, Paris France, 2004.

National and State Peer-Reviewed Abstracts/Platform Presentations ( *corresponding author)

1. Linnebur SA, MacLaughlin EJ, Seaton TL, Ives TJ. 17 Years of Promoting Ambulatory Care: the History of the Ambulatory Care PRN. Abst #365, American College of Clinical Pharmacy Annual Meeting, 2009.

2. MacLaughlin EJ,* Fike DS, Alvarez CA, Seifert CF, Blaszczyk AT. Reliability of a seminar grading rubric in a grand rounds course. Abst #45, American College of Clinical Pharmacy Annual Meeting, 2009.

3. Haase KK, Tawwater JC, MacLaughlin EJ. Emerging adverse effects with aliskiren: increased blood pressure and angioedema. Abst #2, American College of Clinical Pharmacy Annual Meeting, 2008. Pharmacotherapy. 2008;38:116e.

4. MacLaughlin, EJ.* The need for promoting aggressive osteoporosis prevention options in elderly patients. ASHP Midyear Clinical Meeting. 41(Dec): p pi-238. 2006.

5. MacLaughlin, EJ.* Impact of osteoporosis and related fractures: are we missing the boat? ASHP Midyear Clinical Meeting. 41(Dec): p pi-175. 2006.

6. Ballestas C, MacLaughlin EJ,* Fike DS, Zoller D. Failure of primary care physicians to treat high-risk osteoporosis patients. Abst #286, American College of Clinical Pharmacy Annual Meeting, 2006. Pharmacotherapy. 2006;26:e97.

7. Patry RA, MacLaughlin EJ, Young R, Nixon-Lewis B, Veronin M, Zoller DP. Implementation and Analysis of a Pharmacy School-Based Drug Plan for Low Income Patients. Texas Society of Health-System Pharmacists Annual Seminar, 2005.

8. Patry RA, MacLaughlin EJ, Young R, Veronin M, Nixon-Lewis B, Zoller DP. Assessing the impact of a novel drug plan for senior patients: initial analysis. Abst #P26R, American Society of Health-Systems Pharmacists Midyear Clinical Meeting, 2004. 39(DEC): p P26R. 2004.

9. Patry RA, MacLaughlin EJ, Young R, Veronin M, Nixon-Lewis B, Zoller DP. Modeling the impact of medication management and CPOE on adherence to therapeutic guidelines. Abst #9, Texas Society of Health-System Pharmacists Annual Seminar, 2004.

10. MacLaughlin EJ,* Supernaw RB, Howard KA. Impact of distance-learning technology on student performance. Abst #46, American Association of Colleges of Pharmacy Annual Meeting, 2002. 103(JUL): p 33. 2002.

11. MacLaughlin EJ, Saseen JJ, Malone DC. Selection and costs of antibiotics for patients with a reported beta-lactam allergy. Abst #62E, American College of Clinical Pharmacy Spring Meeting, 2001. Pharmacotherapy. 2001;21(3):376.

12. Roach AE, Anderson AC, Berk SL, Haase KK, Akins, RL, MacLaughlin EJ, Nixon-Lewis B, Raehl, CL. A randomized trial of once daily levofloxacin versus once daily ceftriaxone for treatment of nursing home acquired pneumonia and prospective pharmacokinetic study of levofloxacin. American Society of Health-Systems Pharmacists Midyear Clinical Meeting, 2001.

13. Reddy IK, MacLaughlin EJ. Improved student learning in musculoskeletal system course through an interdisciplinary approach using web-based instruction and distance education technology. Abst #40, American Association of Colleges of Pharmacy Annual Meeting. 101(Jul): p 25. 2000.

14. MacLaughlin EJ,* Sterrett JJ. Detaching from a product: community pharmacist reimbursement for diabetes services. Abst #40, American College of Clinical Pharmacy Spring Meeting, 2000. Pharmacotherapy. 2000;20(3):344.

15. MacLaughlin EJ.* Challenges for primary care physicians. ASHP Midyear Clinical Meeting. 35(Dec): p PI-26. 2000.

16. Mehos BM, Saseen JJ, MacLaughlin EJ. Effect of pharmacist initiated home blood pressure monitoring on hypertension. Abst #166E, American College of Clinical Pharmacy Annual Meeting, 1999. Pharmacotherapy 1999;19(10):1218.

Non-Peer Reviewed Abstracts/Platform Presentations ( *corresponding author)

1. Elliott A, MacLaughlin EJ,* Haase KK, Young RB. Is rural America at goal? Healthcare in the panhandle of Texas. Texas Society of Health System Pharmacists ALCADE Southwest Leadership Conference, San Antonio, TX, April 14, 2011.

2. MacLaughlin EJ,* Fike DS, Alvarez CA, Seifert CF, Blaszczyk AT. Reliability of a seminar grading rubric in a grand rounds course. Abst #2, Eight Annual Research Days, TTUHSC, School of Pharmacy, July, 2009.

3. Gallegos PJ, MacLaughlin EJ,* Haase KK. Brain Natriuretic Peptide (BNP) Monitoring in the Outpatient setting: A Retrospective Analysis of Outcomes in Patients Monitored and Treated by Serial BNP. Texas Society of Health System Pharmacists ALCADE Residency Conference, April, 2006.

4. Canales AE, Anderson SL, MacLaughlin EJ, Condren M. Pharmaceutical Care I: Utilization of teaching team training sessions to revitalize the delivery of nonprescription medication curriculum. Nonprescription Medication Academy (NMA). Annual Meeting, September 2005.

5. Patry RA, MacLaughlin EJ, Young R, Veronin M, Nixon-Lewis B, Zoller D, Easterday L. Tech Care assistance for the Medicare Part D donut hole. Abst #40, Fourth Annual Research Days, TTUHSC, School of Pharmacy, July, 2005.

6. Patry RA, MacLaughlin EJ, Young R, Nixon-Lewis B, Veronin M, Zoller D. Assessing the impact of a novel drug plan for senior patients: initial analysis. Abst #40, Third Annual Research Days, TTUHSC, School of Pharmacy, July, 2004.

7. Tavarez TL, Snella KA, MacLaughlin EJ. Contributing factors of patient-nonadherence to prescribed medications. Abst #PL III-4, Texas Society of Health System Pharmacists ALCADE Residency Conference, April, 2004.

8. Condren M, MacLaughlin EJ. Innovations in teaching nonprescription medications. Nonprescription Medication Academy (NMA). Annual Meeting, September 2001.

9. MacLaughlin EJ, Saseen JJ, Malone DC. Should beta-lactam allergies be confirmed in primary care? Midwestern Residency Conference. St. Louis, Missouri, 04/1999.

Audiovisuals/Online Resources

1. MacLaughlin EJ, Covington L, Nguyen T. “Over the Counter Analgesics and the Aged.” TTUHSC Geriatric Education Center. Available at http://www.youtube.com/watch?v=mUR-GqTU23w&feature=youtu.be, released 11/30/2011.

2. MacLaughlin EJ, Vondracek SF, Michaud LB. “Current Controversies in Bone Health and Osteoporosis Prevention and Treatment: The Experts Answer Questions from Health-System Pharmacists.” ASHP Advantage E-Newsletter. Winter 2010. Available at http://www.ashpadvantage.com/bonehealth/bonehealth-winter-nl.pdf.

3. MacLaughlin EJ, Vondracek SF, Michaud LB. “Update on Bone Health and Osteoporosis Prevention and Treatment: The Experts Answer Questions from Health-System Pharmacists.” ASHP Advantage E-Newsletter. Spring 2010. Available at http://www.ashpadvantage.com/bonehealth/bonehealth-spring-2010.pdf.

4. MacLaughlin EJ, Vondracek SF, Michaud LB. ASHP Advantage online CE program: “Looking beyond the ‘obvious’ to promote Bone Health.” Available at http://onlinece.ashpadvantage.com/symposia/bonehealth/activity.html, released 03/01/2010.

5. MacLaughlin EJ. The importance of bone health and risk assessment. ASHP Advantage Podcast Interview for Bone Health Initiative: “Looking beyond the ‘obvious’ to promote bone health, available at http://www.ashpadvantage.com/bonehealth/interviews.html, released 01/08/2010.

6. MacLaughlin EJ, Young RB. Metformin for Type 2 Diabetes. The Texas Tech Medcast. iTunes U Podcast, Released 06/21/2006.

7. Young RB, MacLaughlin EJ. HDL and Triglycerides: Forgotten Lipids (Part I). The Texas Tech Medcast. iTunes U Podcast. Released 06/01/2006.